MINDCURE Launches Second Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research Post published:July 27, 2021 Post category:Press Release
Awakn Life Sciences to Commence Trading on the OTC Market on July 26, 2021 Under the Symbol ‘AWKNF’ Post published:July 26, 2021 Post category:Press Release
Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor Post published:July 26, 2021 Post category:Press Release
Psyched Wellness Enters into a Service Agreement with CannaLabs to Begin Stability Tests on AME-1 Post published:July 26, 2021 Post category:Press Release
Psychedelic Bulletin: Field Trip Set to List on Nasdaq; Cybin to List on NYSE American Post published:July 24, 2021 Post category:Psychedelic Bulletin
Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol “FTRP” Post published:July 23, 2021 Post category:Press Release
PharmaDrug Announces Stock Ticker Symbol Change to (CSE: PHRX) Post published:July 23, 2021 Post category:Press Release
Red Light Holland Announces Updated Cash Position of Approximately $30 Million Post published:July 23, 2021 Post category:Press Release
Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta Post published:July 23, 2021 Post category:Press Release
Levitee Labs Provides Company Update Following CSE Listing Post published:July 22, 2021 Post category:Press Release